For research and educational purposes only. Not intended for human consumption.
Prostamax
Limited Research- •Chronic prostatitis preclinical model data
- •Chromatin deheterochromatinization research
- •Khavinson bioregulator protocol updates
KEDP Tetrapeptide | Prostate Bioregulator
Overview
What is Prostamax?
Prostamax (Lys-Glu-Asp-Pro/KEDP) is a synthetic tetrapeptide bioregulator from the Khavinson peptide family that demonstrates prostate-specific tissue effects. Preclinical research shows anti-inflammatory and tissue-protective properties in chronic prostatitis models, with emerging interest in epigenetic chromatin regulation and anti-aging applications.
Key Benefits
Direct systemic delivery, optimal bioavailability for prostate tissue targeting, established preclinical protocols, anti-inflammatory and tissue-protective properties.
Mechanism of Action
Subcutaneous injection provides systemic circulation for tissue-specific bioregulation of prostate gland cells. Induces deheterochromatinization (chromatin relaxation) potentially reversing age-related gene silencing.
Molecular Information
Pharmacokinetics
Research Indications
Chronic Prostatitis
Preclinical studies show reduced inflammation markers including tissue swelling, vascular hyperemia, and lymphoid infiltration.
Anti-Sclerotic Effects
Prevention of sclerotic and atrophic processes in chronic inflammatory prostate conditions.
Tissue Regeneration
Enhanced proliferative and metabolic activity in prostate epithelial cells and fibroblasts.
Research Protocols
Disclaimer: Human clinical trial data limited. Dosing extrapolated from preclinical models. Contraindicated with active prostate malignancy.
| Goal | Dose | Frequency | Route |
|---|---|---|---|
| Prostate Health Support | 0.5-1mg | Once daily | Subcutaneous |
| Anti-Aging Protocol | 0.75mg | Once daily for 10-20 days | Subcutaneous |
| Preclinical Reference | 20 μg/kg | Daily for 15 days | Intramuscular |
Timing: Morning administration recommended. Rotate injection sites.
Peptide Interactions
How to Reconstitute
Important: Always use bacteriostatic water (BAC). Sterile technique is essential.
Allow vial to reach room temperature
Clean vial top with alcohol
Add 2.0mL BAC water for 10mg/mL concentration
Inject slowly down side of vial
Gently swirl - do not shake
Store reconstituted at 2-8°C, use within 14 days
Dosing Calculator
Calculate your injection volume with visual dosing guide
To obtain 250 mcg from this solution:
Draw 0.10 mL=10 units
(1 mL = 100 units on any insulin syringe)
Draw to this mark for 250 mcg
This calculator is for research purposes only. Always verify calculations and consult protocols.
Quality Indicators
White lyophilized powder
White to off-white freeze-dried powder.
Clear reconstituted solution
Crystal clear with no particles.
Certificate of Analysis
Third-party testing showing 99%+ purity.
Discolored or clumped
Yellow, brown, or heavily clumped indicates degradation.
What to Expect
- •Week 1-2: Subtle improvements, reduced inflammation markers
- •Week 2-3: Enhanced tissue function based on animal studies
- •Week 3-4: Peak effects observed in preclinical protocols
Side Effects & Safety
Side Effects
- •Human clinical data limited - extrapolated from preclinical
- •Possible mild injection site reactions
- •Rare digestive discomfort or headache
- •Contraindicated with active prostate malignancy
- •Quality sourcing critical
When to Stop
- •Adverse effects
- •Any prostate abnormalities
- •As directed by provider
References
2 StudiesChronic Aseptic Prostatitis Study (2013)
Rat model | 20 μg/kg IM | 45 days | Reduced inflammation, enhanced sexual activity
Prostamax reduced swelling, hyperemia, lymphoid infiltration. Efficacy surpassed Serenoa repens and animal prostate extracts.
Deheterochromatinization Study (2012)
Human cell cultures | Elderly subjects | Chromatin relaxation
KEDP induces deheterochromatinization potentially reversing age-related gene silencing.
View StudyQuick Start Guide
Research Disclaimer
Prostamax is sold for laboratory research purposes only and is not intended for human or animal consumption. The information provided on this page is compiled from published research, veterinary studies, and anecdotal reports for educational purposes. This content does not constitute medical advice, diagnosis, or treatment recommendations. Any research involving Prostamax must comply with all applicable local, state, and federal regulations. BioInfinity Lab makes no claims regarding the safety or efficacy of Prostamax for any purpose. Consult qualified professionals for any research applications.